Skip to main content

ORIGINAL RESEARCH article

Front. Pediatr.
Sec. Pediatric Hematology and Hematological Malignancies
Volume 13 - 2025 | doi: 10.3389/fped.2025.1480213
This article is part of the Research Topic Vascular Malformations: Advancements, Debates, and Consensus View all 7 articles

Similarities and differences in the clinical features and management of primary lymphedema and kaposiform hemangioendothelioma associated with lymphedema in children

Provisionally accepted
  • West China Hospital, Sichuan University, Chengdu, China

The final, formatted version of the article will be published soon.

    Background: Primary lymphedema (PLE) and kaposiform hemangioendothelioma-related lymphedema (KLE) are rare vascular anomalies (VAs). The aim of this study was to examine the clinical features, management and prognosis of PLE and KLE.The clinical features, imaging, treatments and outcomes of 12 patients with PLE and 12 patients with KLE were retrospectively reviewed.The mean age at which signs/symptoms were diagnosed was 68.2 months for PLE patients and 25.0 months for KLE patients. In PLE, the involvement of multiple sites is common, whereas in KLE, it typically affects a single site. Morbid obesity, which is common in adult patients, is rare in pediatric PLE and KLE patients. Imaging agent accumulation was observed in KLE but not in PLE via lymphoscintigraphy. In contrast, complications of PLE primarily involve skin and soft tissue, whereas musculoskeletal system complications are more common in KLE. In terms of prognosis, most patients stabilize or even experience lesion regression after standard treatment.PLE and KLE share clinical symptoms. PLE often involves multiple sites, whereas KLE typically presents unilaterally with local lymphatic stasis. Standardized treatment enables the majority of children with lymphedema to control the disease without progression, with KLE showing potential reversibility. Given their rarity, a multidisciplinary approach is crucial for diagnosis and management.

    Keywords: Primary lymphedema, Kaposiform hemangioendothelioma, Clinical Characteristics, complications, Treatment

    Received: 05 Sep 2024; Accepted: 23 Jan 2025.

    Copyright: © 2025 Zhang, Qiu, Yang, Zhou, Yang, Gong, Zhang, Lan, Zhang, Chen and Ji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yi Ji, West China Hospital, Sichuan University, Chengdu, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.